Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above
Clinical trial NCT01867021 · COMPLETED
Trial details
- NCT number
- NCT01867021
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-12-01
- Enrollment
- 2902
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.